CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: RES-701-1
Accession: CHEBI:223170
browse the term
Synonyms: exact_synonym: (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(3S,12S,15S,18S,25S)-6-acetyl-18-(2-amino-2-oxoethyl)-12-(1H-imidazol-5-ylmethyl)-15-(1H-indol-3-ylmethyl)-3-methyl-2,5,8,11,14,17,20,23,27-nonaoxo-1,4,7,10,13,16,19,22,26-nonazabicyclo[26.3.0]hentriacontane-25-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-amino-4-oxobutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid
related_synonym: Formula=C103H113N23O23; InChI=1S/C103H113N23O23/c1-54-102(147)126-35-15-26-83(126)100(145)123-81(46-86(132)110-51-87(133)114-79(44-84(104)130)97(142)119-77(41-61-48-108-70-24-13-10-21-67(61)70)96(141)121-78(43-63-50-106-53-112-63)90(135)111-52-88(134)125-89(55(2)127)101(146)113-54)99(144)120-76(40-60-47-107-69-23-12-9-20-66(60)69)95(140)117-72(36-56-16-5-3-6-17-56)91(136)115-73(37-57-18-7-4-8-19-57)93(138)122-80(45-85(105)131)98(143)118-74(38-58-27-31-64(128)32-28-58)92(137)116-75(39-59-29-33-65(129)34-30-59)94(139)124-82(103(148)149)42-62-49-109-71-25-14-11-22-68(62)71/h3-14,16-25,27-34,47-50,53-54,72-83,89,107-109,128-129H,15,26,35-46,51-52H2,1-2H3,(H2,104,130)(H2,105,131)(H,106,112)(H,110,132)(H,111,135)(H,113,146)(H,114,133)(H,115,136)(H,116,137)(H,117,140)(H,118,143)(H,119,142)(H,120,144)(H,121,141)(H,122,138)(H,123,145)(H,124,139)(H,125,134)(H,148,149)/t54-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83?,89?/m0/s1; InChIKey=QEHKVSXORDXCMU-SOEAEWQVSA-N; SMILES=O=C1N2C(C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC=3C4=C(C=CC=C4)NC3)CC5=CC=C(O)C=C5)CC6=CC=C(O)C=C6)CC(=O)N)CC7=CC=CC=C7)CC8=CC=CC=C8)CC=9C%10=C(C=CC=C%10)NC9)CC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(N[C@H](C(NCC(NC(C(N[C@H]1C)=O)C(=O)C)=O)=O)CC=%11NC=NC%11)=O)CC=%12C%13=C(C=CC=C%13)NC%12)CC(=O)N)CCC2
xref: Chemspider:78442670
xref_mesh: MESH:C087120
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
RES 701-1 affects the reaction [sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]]
CTD
PMID:23152186
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Edn1
endothelin 1
multiple interactions
EXP
RES 701-1 inhibits the reaction [EDN1 protein results in decreased secretion of NPY protein]
CTD
PMID:12234805
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Ins2
insulin 2
multiple interactions
ISO
RES 701-1 affects the reaction [sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]]
CTD
PMID:23152186
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Npy
neuropeptide Y
multiple interactions
EXP
RES 701-1 inhibits the reaction [EDN1 protein results in decreased secretion of NPY protein]
CTD
PMID:12234805
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all